FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labeling with the changes d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Exercise-induced Bronchoconstriction
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• SINGULAIR (montelukast)

Snippet

SUPPL AP for SINGULAIR (MONTELUKAST SODIUM)